ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cerebrovascular disease"

  • Abstract Number: 2856 • 2014 ACR/ARHP Annual Meeting

    Update on Long-Term Outcomes after Reversible Cerebral Vasoconstriction Syndrome (RCVS)

    Seby John1, Aneesh Singhal2, Leonard H. Calabrese3, Ken Uchino4, Tariq Hammad3, Stewart Tepper3, Mark Stillman3 and Rula A Hajj-Ali5, 19500 Euclid Avenue S10-C, Cleveland Clinic Foundation, Cleveland, OH, 2Neurology, Massachusetts General Hospital, Boston, MA, 3Cleveland Clinic Foundation, Cleveland, OH, 4Neurology, Cleveland Clinic Foundation, Cleveland, OH, 5Rheumatology, Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose RCVS is characterized by acute onset of severe headaches, with or without neurologic deficit with evidence of reversible cerebral vasoconstriction. We have previously reported…
  • Abstract Number: 2765 • 2014 ACR/ARHP Annual Meeting

    Putative Blood Biomarkers of Reversible Cerebral Vasoconstriction Syndrome  

    Seby John1, Belinda Willard2, Leonard H. Calabrese2, Ken Uchino3, Tariq Hammad2, Stewart Tepper2, Mark Stillman2 and Rula A Hajj-Ali4, 19500 Euclid Avenue S10-C, Cleveland Clinic Foundation, Cleveland, OH, 2Cleveland Clinic Foundation, Cleveland, OH, 3Neurology, Cleveland Clinic Foundation, Cleveland, OH, 4Rheumatology, Cleveland Clinic Foundation, Cleveland, OH

     Putative blood biomarkers of Reversible Cerebral Vasoconstriction Syndrome Background/Purpose The pathophysiology and molecular mechanisms of Reversible Cerebral Vasoconstriction Syndrome (RCVS) are unknown. Objective of the…
  • Abstract Number: 1852 • 2014 ACR/ARHP Annual Meeting

    Increased Cardiovascular Risk in Patients Recently Diagnosed with Psoriatic Arthritis: A Population-Based, Cohort Study

    Katelynn Wilton1, Floranne C. Ernste2, Cynthia S. Crowson3, Eric L. Matteson4, Hilal Maradit Kremers5 and Marta Sánchez-Menéndez6, 1Medical Scientist Training Program, Mayo Clinic Rochester, Rochester, MN, 2Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Rheumatology, Mayo Clinic, Rochester, MN, 5Health Sciences Research, Mayo Clinic, Rochester, MN, 6Centro Medico de Asturias, Oviedo, Spain

    Background/Purpose: Patients diagnosed with rheumatoid arthritis and psoriatic arthritis (PsA) have an increased risk of multiple comorbidities that predispose them to cardiovascular disease (CVD). Although…
  • Abstract Number: 1865 • 2014 ACR/ARHP Annual Meeting

    Increased Risk of Myocardial Infarction and Cerebrovascular Accidents after Diagnosis of Granulomatosis with Polyangiitis: A General Population-Based Cohort Study

    Neda Amiri1, Natasha Dehghan2, Eric C. Sayre3, Kamran Shojania1 and J. Antonio Avina-Zubieta4, 1Rheumatology, University of British Columbia, Vancouver, BC, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada

    Background/Purpose Limited literature is available on the incidence of myocardial infarction (MI) and cerebrovascular accidents (CVA) in patients with Granulomatosis with Polyangiitis (GPA).  We assessed…
  • Abstract Number: 1081 • 2014 ACR/ARHP Annual Meeting

    Prediction of Mortality Risk Related to Cerebrovascular Accidents in Patients with Systemic Lupus Erythematosus (SLE) vs Anti-Phospho-Lipid-Antibody (aPL) syndrome

    Khushboo Sheth1, Tapan Mehta2, Sonam Puri1, Ronak Soni3 and Kathan Mehta4, 1Internal Medicine, University of Connecticut, Farmington, CT, Farmington, CT, 2Neurology, University of Connecticut, Farmington, CT, Farmington, CT, 3Internal Medicine, Government Medical College, Surat, India, 4Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, Pittsburgh, PA

    Background/Purpose : It is well-established that patients with co-existent Systemic Lupus Erythematosus (SLE) and Anti-Phospho-Lipid-Antibody (aPL) syndrome are at increased risk of cerebrovascular accidents (CVA).…
  • Abstract Number: 726 • 2014 ACR/ARHP Annual Meeting

    Risk of Ischemic Stroke in Patients with Systemic Sclerosis: A Systematic Review and Meta-Analysis

    Patompong Ungprasert1, Praveen Ratanasrimetha2, Charat Thongprayoon3, Wisit Cheungpasitporn3 and Promporn Suksaranjit4, 1Department of Internal medicine, Bassett medical center, Cooperstown, NY, 2Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 3Department of Medicine, Mayo clinic, Rochester, MN, 4Department of Cardiology, University of Utah School of Medicine, Salt Lake City, UT

    Risk of Ischemic Stroke in Patients with Systemic Sclerosis: A Systematic Review and Meta-analysisBackground/Purpose: Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus…
  • Abstract Number: 2386 • 2012 ACR/ARHP Annual Meeting

    Disability and Mortality Related to Cerebrovascular Disease in Systemic Vasculitis

    Jamal Mikdashi1 and Marcia Wozniak2, 1Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, 2Department of Neurology, University of Maryland School of Medicine, Baltimore, MD

    Background/Purpose: Despite improved therapeutic strategies, patients with systemic vasculitis (SV) continue to experience serious morbidity and mortality from persistent low grade disease activity and permanent…
  • Abstract Number: 2221 • 2012 ACR/ARHP Annual Meeting

    Major Adverse Cardiovascular Events Are More Common in Rheumatoid Arthritis Than in Psoriatic Arthritis and Are Associated with Different Risk Factors

    Allen P. Anandarajah1, Katherine C. Saunders2, George W. Reed3, Alina U. Onofrei3, Jeffrey D. Greenberg4 and Christopher T. Ritchlin5, 1Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, 2Corrona, LLC., Southborough, MA, 3University of Massachusetts Medical School, Worcester, MA, 4NYU Hospital for Joint Diseases, New York, NY, 5Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY

    Background/Purpose: Rheumatoid Arthritis (RA) is associated with increased cardiovascular mortality and morbidity rates. Similarly several studies have reported an increased risk for cardiovascular events in…
  • Abstract Number: 1551 • 2012 ACR/ARHP Annual Meeting

    Primary Angiitis of the Central Nervous System: Description of the First 52 Adult Patients Enrolled in the French COVAC’ Cohort

    Hubert de Boysson1, Mathieu Zuber2, Olivier Naggara3, Jean-Philippe Neau4, Françoise Gray5, Marie-Germaine Bousser6, Isabelle Crassard6, Emmanuel Touze7, Pierre-Olivier Couraud8, Philippe Kerschen9, Catherine Oppenheim3, Olivier Detante10, Anthony Faivre11, Nicolas Gaillard12, Caroline Arquizan13, Boris Bienvenu14, Antoine Neel15, Loic Guillevin16, Christian Pagnoux17 and French Vasculitis Study Group and NeuroVascular Society18, 1Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, 2Department of Neurology, Groupe Hospitalier Saint-Joseph, Université Paris Descartes, Paris, France, 3Department of Neuroradiology, Hôpital Sainte-Anne, Paris, France, 4Department of Neurology, Centre Hospitalier Universitaire La Milétrie, Poitiers, France, 5Department of Pathology, APHP Hôpital Lariboisière, Université Paris Diderot, Paris, France, 6Department of Neurology, APHP Hôpital Lariboisière, Université Paris Diderot, Paris, France, 7Department of Neurology, Hôpital Sainte-Anne, Université Paris Descartes, Paris, France, 8Department of Cellular Biology, Institut Cochin, Paris, France, 9Department of Neurology, Centre Hospitalier Universitaire Henri Mondor, Créteil, France, 10Department of Neurology, Centre Hospitalier Universitaire de Grenoble, Grenoble, France, 11Department of Neurology, Hôpital d'Instruction des Armées Saint-Anne, Toulon, France, 12Department of Neurology, Centre Hospitalier de Perpignan, Perpignan, France, 13Department of Neurology, Hôpital Gui de Chauliac, Université Montpellier, Montpellier, France, 14Division of Internal Medicine, Centre Hospitalier Régional Universitaire de Caen, Côte de Nacre, Caen, France, Caen, France, 15Department of Internal Medicine, Centre Hospitalier Universitaire de Nantes, Nantes, France, 16Internal Medicine, Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, 17Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada, 18Paris, France

    Background/Purpose: Primary angiitis of the central nervous system (PACNS) is rare and only 1 pediatric and 1 adult large cohorts including >30 PACNS patients have…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology